Zobrazeno 1 - 10
of 132
pro vyhledávání: '"Lilla Tamási"'
Autor:
Gábor Tomisa, Balázs Sánta, Alpár Horváth, László Németh, Balázs Tamás, Gabriella Gálffy, Lilla Tamási, Noémi Eszes
Publikováno v:
BMJ Open Respiratory Research, Vol 11, Iss 1 (2024)
Introduction Asthma is the most prevalent obstructive pulmonary disease, with drastically improved treatment options over the past decades. However, there is still a proportion of patients with suboptimal level of asthma control, leading to multiple
Externí odkaz:
https://doaj.org/article/653c5d52e7db485890084616faf7f727
Autor:
Gabriella Gálffy, Géza Tamás Szabó, Lilla Tamási, Veronika Müller, Judit Moldvay, Veronika Sárosi, Anna Kerpel-Fronius, Tamás Kardos, Edit Csada, Zsolt Pápai-Székely, Zoltán Szász, Zsolt Király, Gábor Hódi, Zsuzsanna Kovács, Éva Balogh, Krisztina Andrea Kovács, Miklós Darida, Viktória Buga, György Rokszin, Zsolt Abonyi-Tóth, Zoltán Kiss, Zoltán Vokó, Krisztina Bogos
Publikováno v:
Pathology and Oncology Research, Vol 30 (2024)
ObjectiveHungary has repeatedly been shown to have the highest cancer-related mortality and incidence in Europe. Despite lung cancer being the most abundant malignant diagnosis in Hungary, numerous concerns have been raised recently regarding the bia
Externí odkaz:
https://doaj.org/article/9bde8f083408482c872f58d4f50c4120
Autor:
Zoltán Kiss, Gabriella Gálffy, Veronika Müller, Judit Moldvay, Veronika Sárosi, Zsolt Pápai-Székely, Edit Csada, Anna Kerpel-Fronius, Zsolt Király, Zoltán Szász, Gábor Hódi, Zoltán Polányi, Krisztina Kovács, Eugenia Karamousouli, Kata Knollmajer, Tamás G. Szabó, Andrea Berta, Zoltán Vokó, György Rokszin, Zsolt Abonyi-Tóth, Zsófia Barcza, Lilla Tamási, Krisztina Bogos
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
ObjectiveThe approval of immunotherapy (I-O) for the treatment of late-stage non-small cell lung cancer (NSCLC) opened new perspectives in improving survival outcomes. However, survival data have not yet been provided from the period of the Covid-19
Externí odkaz:
https://doaj.org/article/af41d80cfb264262bce0e68d6b8a2c77
Autor:
Zsófia Lázár, Alpár Horváth, Szilvia Kiss-Dala, Zsolt Abonyi-Tóth, Balázs Csoma, Katalin Kontz, Lilla Tamási, Veronika Müller
Publikováno v:
European Clinical Respiratory Journal, Vol 11, Iss 1 (2024)
ABSTRACTBackground The criteria for significant bronchodilator responsiveness (BDR) were published in 2005 by the European Respiratory Society/American Thoracic Society, which were revised in 2021, however, data on the agreement between these two rec
Externí odkaz:
https://doaj.org/article/4930a6088806412eb536fe47b79fce6b
Publikováno v:
Allergy, Asthma & Clinical Immunology, Vol 17, Iss 1, Pp 1-14 (2021)
Abstract Background The prevalence of comorbidities and their relation to asthma control and treatment is a topic of increasing interest, however comprehensive studies are scarce. We aimed to determine the prevalence of the most common comorbidities
Externí odkaz:
https://doaj.org/article/e52fb9d159fd437bae45d2909a1347a7
Autor:
Zolta´n Kiss, Krisztina Bogos, Lilla Tamási, Gyula Ostoros, Veronika Müller, Nóra Bittner, Veronika Sárosi, Aladár Vastag, Kata Knollmajer, Máté Várnai, Krisztina Kovács, Andrea Berta, István Köveskuti, Eugenia Karamousouli, György Rokszin, Zsolt Abonyi-Tóth, Zsófia Barcza, István Kenessey, András Weber, Péter Nagy, Petra Freyler-Fadgyas, Miklós Szócska, Péter Szegner, Lászlóné Hilbert, Gabriella Branyiczkiné Géczy, György Surján, Judit Moldvay, Zoltán Vokó, Gabriella Gálffy, Zoltán Polányi
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
ObjectiveThe Hungarian Undiagnosed Lung Cancer (HULC) study aimed to explore the potential reasons for missed LC (lung cancer) diagnosis by comparing healthcare and socio-economic data among patients with post-mortem diagnosed LC with those who were
Externí odkaz:
https://doaj.org/article/dc1a39dc32514d11b8d8fffbd26a0f45
Autor:
Zsófia Gál, András Gézsi, Ágnes F. Semsei, Adrienne Nagy, Monika Sultész, Zsuzsanna Csoma, Lilla Tamási, Gabriella Gálffy, Csaba Szalai
Publikováno v:
Journal of Translational Medicine, Vol 18, Iss 1, Pp 1-15 (2020)
Abstract Background In the present study the blood expression level of inflammatory response and autoimmunity associated long non-coding RNAs (lncRNAs) were compared in patients with different chronic respiratory diseases and investigated whether the
Externí odkaz:
https://doaj.org/article/6e4acede9ea3417a8ff993ddc62ae7aa
Publikováno v:
Pulmonary Therapy, Vol 5, Iss 2, Pp 165-177 (2019)
Plain Language Summary Introduction Long-lasting symptoms and reduced quality of life are common in patients with asthma and chronic obstructive pulmonary disease (COPD). Current therapies are only partially effective and handling/usage errors can af
Externí odkaz:
https://doaj.org/article/ae200e459fdd4270b1333861794722ca
Autor:
Zsófia Gál, András Gézsi, Viktor Molnár, Adrienne Nagy, András Kiss, Monika Sultész, Zsuzsanna Csoma, Lilla Tamási, Gabriella Gálffy, Bálint L. Bálint, Szilárd Póliska, Csaba Szalai
Publikováno v:
Frontiers in Genetics, Vol 11 (2020)
Externí odkaz:
https://doaj.org/article/87e2f32d1ae34e378e3bbd82207bee28
Autor:
Zsófia Gál, András Gézsi, Viktor Molnár, Adrienne Nagy, András Kiss, Monika Sultész, Zsuzsanna Csoma, Lilla Tamási, Gabriella Gálffy, Bálint L. Bálint, Szilárd Póliska, Csaba Szalai
Publikováno v:
Frontiers in Genetics, Vol 11 (2020)
Tie2, coded by the TEK gene, is a tyrosine kinase receptor and plays a central role in vascular stability. It was suggested that variations in the TEK gene might influence the susceptibility to asthma and allergic conjunctivitis. The aim of this stud
Externí odkaz:
https://doaj.org/article/51dc182587ec455685f1f211cadc4891